ENTA – Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals, Inc.ENTA
$5.10Name : Enanta Pharmaceuticals, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $108,795,744.00
EPSttm : -4.95
Enanta Pharmaceuticals, Inc.
$5.10
3.45%$0.17Float Short %
13.46
Margin Of Safety %
Put/Call OI Ratio
0.33
EPS Next Q Diff
-0.21
EPS Last/This Y
1.06
EPS This/Next Y
-0.11
Price
5.1
Target Price
15.33
Analyst Recom
2.17
Performance Q
5.15
Relative Volume
0.5
Beta
0.85
Ticker: ENTA
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-20 | ENTA | 6.44 | 0.38 | 0.17 | 1008 |
| 2025-03-21 | ENTA | 6.33 | 0.38 | 1.52 | 1010 |
| 2025-03-24 | ENTA | 6.21 | 0.29 | 0.25 | 628 |
| 2025-03-25 | ENTA | 5.88 | 0.29 | 0.25 | 628 |
| 2025-03-26 | ENTA | 5.86 | 0.30 | 0.00 | 632 |
| 2025-03-27 | ENTA | 5.85 | 0.30 | 0.00 | 632 |
| 2025-03-28 | ENTA | 5.7 | 0.29 | 0.00 | 647 |
| 2025-03-31 | ENTA | 5.51 | 0.29 | 0.46 | 649 |
| 2025-04-01 | ENTA | 5.32 | 0.30 | 0.00 | 725 |
| 2025-04-02 | ENTA | 5.3 | 0.30 | 0.00 | 725 |
| 2025-04-03 | ENTA | 5.04 | 0.30 | 999.99 | 735 |
| 2025-04-04 | ENTA | 4.72 | 0.33 | 0.00 | 754 |
| 2025-04-07 | ENTA | 4.63 | 0.33 | 0.67 | 754 |
| 2025-04-08 | ENTA | 4.47 | 0.34 | 999.99 | 769 |
| 2025-04-09 | ENTA | 4.53 | 0.38 | 9.50 | 796 |
| 2025-04-10 | ENTA | 4.27 | 0.41 | 999.99 | 811 |
| 2025-04-11 | ENTA | 4.71 | 0.44 | 0.00 | 831 |
| 2025-04-14 | ENTA | 4.93 | 0.36 | 0.12 | 954 |
| 2025-04-15 | ENTA | 5.16 | 0.34 | 3.00 | 1042 |
| 2025-04-16 | ENTA | 4.94 | 0.34 | 1.20 | 1042 |
| 2025-04-17 | ENTA | 5.13 | 0.33 | 0.00 | 1032 |
| 2025-04-18 | ENTA | 5.1 | 0.33 | 0.00 | 1032 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-20 | ENTA | 6.44 | 22.7 | - | -4.42 |
| 2025-03-21 | ENTA | 6.33 | 22.7 | - | -4.42 |
| 2025-03-24 | ENTA | 6.20 | 22.7 | - | -4.42 |
| 2025-03-25 | ENTA | 5.88 | 22.7 | - | -4.42 |
| 2025-03-26 | ENTA | 5.86 | 22.7 | - | -4.42 |
| 2025-03-27 | ENTA | 5.86 | 22.7 | - | -4.42 |
| 2025-03-28 | ENTA | 5.71 | 22.7 | - | -4.42 |
| 2025-03-31 | ENTA | 5.52 | 22.7 | - | -4.42 |
| 2025-04-01 | ENTA | 5.32 | 22.7 | - | -4.42 |
| 2025-04-02 | ENTA | 5.30 | 22.7 | - | -4.42 |
| 2025-04-03 | ENTA | 5.05 | 22.7 | - | -4.42 |
| 2025-04-04 | ENTA | 4.73 | 22.7 | - | -4.42 |
| 2025-04-07 | ENTA | 4.64 | 22.7 | - | -4.42 |
| 2025-04-08 | ENTA | 4.46 | 22.7 | - | -4.42 |
| 2025-04-09 | ENTA | 4.50 | 22.7 | - | -4.42 |
| 2025-04-10 | ENTA | 4.27 | 22.7 | - | -4.42 |
| 2025-04-11 | ENTA | 4.69 | 22.7 | - | -4.42 |
| 2025-04-14 | ENTA | 4.93 | 22.7 | - | -4.42 |
| 2025-04-15 | ENTA | 5.15 | 22.7 | - | -4.42 |
| 2025-04-16 | ENTA | 4.92 | 22.7 | - | -4.42 |
| 2025-04-17 | ENTA | 5.10 | 22.7 | - | -4.42 |
| 2025-04-18 | ENTA | 5.10 | 22.7 | - | -4.42 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-20 | ENTA | 1.97 | -6.15 | 13.11 |
| 2025-03-21 | ENTA | 1.97 | -6.15 | 13.11 |
| 2025-03-24 | ENTA | 1.97 | -6.15 | 13.11 |
| 2025-03-25 | ENTA | 1.97 | -6.15 | 13.11 |
| 2025-03-26 | ENTA | 1.97 | -6.15 | 13.28 |
| 2025-03-27 | ENTA | 1.97 | -6.15 | 13.28 |
| 2025-03-28 | ENTA | 1.97 | -6.15 | 13.28 |
| 2025-03-31 | ENTA | 1.97 | -6.31 | 13.28 |
| 2025-04-01 | ENTA | 1.97 | -6.31 | 13.28 |
| 2025-04-02 | ENTA | 1.97 | -6.31 | 13.28 |
| 2025-04-03 | ENTA | 1.97 | -6.31 | 13.28 |
| 2025-04-04 | ENTA | 1.97 | -6.31 | 13.28 |
| 2025-04-07 | ENTA | 1.97 | -6.13 | 13.28 |
| 2025-04-08 | ENTA | 1.97 | -6.13 | 13.28 |
| 2025-04-09 | ENTA | 1.97 | -6.13 | 13.28 |
| 2025-04-10 | ENTA | 1.97 | -6.13 | 13.46 |
| 2025-04-11 | ENTA | 1.97 | -6.13 | 13.46 |
| 2025-04-14 | ENTA | 1.97 | -6.11 | 13.46 |
| 2025-04-15 | ENTA | 1.97 | -6.11 | 13.46 |
| 2025-04-16 | ENTA | 1.97 | -6.11 | 13.46 |
| 2025-04-17 | ENTA | 1.97 | -6.11 | 13.46 |
| 2025-04-18 | ENTA | 1.97 | -6.11 | 13.46 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.05
Avg. EPS Est. Current Quarter
-1.14
Avg. EPS Est. Next Quarter
-1.26
Insider Transactions
1.97
Institutional Transactions
-6.11
Beta
0.85
Average Sales Estimate Current Quarter
15
Average Sales Estimate Next Quarter
15
Fair Value
Quality Score
25
Growth Score
27
Sentiment Score
71
Actual DrawDown %
95
Max Drawdown 5-Year %
-95.6
Target Price
15.33
P/E
Forward P/E
PEG
P/S
1.63
P/B
0.97
P/Free Cash Flow
EPS
-4.95
Average EPS Est. Cur. Y
-4.42
EPS Next Y. (Est.)
-4.53
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-157.57
Relative Volume
0.5
Return on Equity vs Sector %
-113.8
Return on Equity vs Industry %
-100.4
EPS 1 7Days Diff
EPS 1 30Days Diff
0.78
EBIT Estimation
Enanta Pharmaceuticals, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 131
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
stock quote shares ENTA – Enanta Pharmaceuticals Inc Stock Price stock today
news today ENTA – Enanta Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ENTA – Enanta Pharmaceuticals Inc yahoo finance google finance
stock history ENTA – Enanta Pharmaceuticals Inc invest stock market
stock prices ENTA premarket after hours
ticker ENTA fair value insiders trading